Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Epitalon vs FOXO4-DRI
An educational, source-based comparison of Epitalon and FOXO4-DRI — how each peptide works, what it's researched for, and what to know before going deeper.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on epithalamin, a pineal gland extract. Research from Russian gerontology groups has examined effects on telomerase activity, melatonin rhythm, and lifespan in rodent and limited human cohorts.
- Telomerase activity (in vitro)
- Circadian and melatonin rhythm
- Age-related morbidity in long-term Russian cohort studies
- • Most research is Russian and methodologically heterogeneous.
- • Not FDA-approved.
- • Independent replication is limited.
A D-retro-inverso peptide that disrupts the FOXO4-p53 interaction inside senescent cells, selectively triggering their apoptosis while sparing healthy cells in preclinical models.
- Senescent cell clearance
- Tissue function in aged mice
- Fibrotic disease models
- • No human trials; safety and pharmacokinetics in humans unknown.
- • Not FDA-approved.
Epitalon vs FOXO4-DRI — Key differences
- Class: Epitalon is classified as Longevity · Circadian, while FOXO4-DRI is Longevity · Senolytic.
- Primary research focus: Epitalon — telomerase activity (in vitro); FOXO4-DRI — senescent cell clearance.
- Tag: Longevity vs Longevity · Senolytic.